Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
US9931353B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2015 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | May 5, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating an individual having Cerebral Amyloid Angiopathy by using pharmacological chaperones to increase the activity of gangliosidase and/or sialidase enzymes involved in ganglioside catabolism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.